BioSenic S.A. (BIOS.BR)

EUR 0.0

(0.0%)

Net Income Summary of BioSenic S.A.

BioSenic S.A.'s latest annual net income in 2023 was -28.77 Million EUR , down -1310.0% from previous year.
BioSenic S.A.'s latest quarterly net income in 2024 Q2 was 247.5 Thousand EUR , down 0.0% from previous quarter.
BioSenic S.A. reported an annual net income of -2.04 Million EUR in 2022, up 84.21% from previous year.
BioSenic S.A. reported an annual net income of -12.92 Million EUR in 2021, down -8.25% from previous year.
BioSenic S.A. reported a quarterly net income of 247.5 Thousand EUR for 2024 Q1, up 106.24% from previous quarter.
BioSenic S.A. reported a quarterly net income of -28.77 Million EUR for 2023 FY, down -1310.0% from previous quarter.

Annual Net Income Chart of BioSenic S.A. (2023 - 2012)

Historical Annual Net Income of BioSenic S.A. (2023 - 2012)

Year	Net Income	Net Income Growth
2023	-28.77 Million EUR	-1310.0%
2022	-2.04 Million EUR	84.21%
2021	-12.92 Million EUR	-8.25%
2020	-11.94 Million EUR	-14.14%
2019	-10.46 Million EUR	26.42%
2018	-14.21 Million EUR	-11.5%
2017	-12.75 Million EUR	1.82%
2016	-12.98 Million EUR	8.17%
2015	-14.14 Million EUR	-146.67%
2014	-5.73 Million EUR	-40.57%
2013	-4.07 Million EUR	-10.57%
2012	-3.68 Million EUR	0.0%

Year	Net Income	Net Income Growth
2024 Q2	247.5 Thousand EUR	0.0%
2024 Q1	247.5 Thousand EUR	106.24%
2023 FY	-28.77 Million EUR	-1310.0%
2023 Q1	-10.42 Million EUR	-1276.68%
2023 Q2	-20.84 Million EUR	-100.0%
2023 Q3	-3.96 Million EUR	80.96%
2023 Q4	-3.96 Million EUR	0.0%
2022 Q4	-757 Thousand EUR	0.0%
2022 FY	-2.04 Million EUR	84.21%
2022 Q3	-757 Thousand EUR	76.44%
2022 Q2	-3.21 Million EUR	0.0%
2021 Q4	-6.85 Million EUR	0.0%
2021 FY	-12.92 Million EUR	-8.25%
2021 Q2	-6.07 Million EUR	0.0%
2020 Q4	-2.11 Million EUR	0.0%
2020 FY	-11.94 Million EUR	-14.14%
2020 Q2	-9.83 Million EUR	0.0%
2019 FY	-10.46 Million EUR	26.42%
2019 Q2	-5.53 Million EUR	0.0%
2019 Q4	-4.92 Million EUR	0.0%
2018 Q4	-5.76 Million EUR	0.0%
2018 FY	-14.21 Million EUR	-11.5%
2017 FY	-12.75 Million EUR	1.82%
2016 FY	-12.98 Million EUR	8.17%
2015 FY	-14.14 Million EUR	-146.67%
2014 Q3	-1.12 Million EUR	0.0%
2014 FY	-5.73 Million EUR	-40.57%
2014 Q4	-1.88 Million EUR	-67.5%
2013 Q4	-1.34 Million EUR	0.0%
2013 FY	-4.07 Million EUR	-10.57%
2012 FY	-3.68 Million EUR	0.0%

Peer Net Income Comparison of BioSenic S.A.

Name	Net Income	Net Income Difference
Nicox S.A.	-20.88 Million EUR	-37.819%
European Medical Solutions	-709 Thousand EUR	-3958.956%
FERMENTALG	-14.14 Million EUR	-103.407%
argenx SE	-272.91 Million EUR	89.455%
Celyad Oncology SA	-8.44 Million EUR	-240.649%
Hyloris Pharmaceuticals SA	-15.38 Million EUR	-87.113%
Onward Medical N.V.	-36.18 Million EUR	20.461%
Oxurion NV	-18.96 Million EUR	-51.711%
PHAXIAM Therapeutics S.A.	-23.48 Million EUR	-22.522%
Financière de Tubize SA	88.15 Million EUR	132.646%
UCB SA	343 Million EUR	108.39%